Glostrup Hospital, University of Copenhagen
Glostrup Municipality, 2600, Denmark
NCT Number: NCT02203929
Knowledge of the natural history and progression of macular holes is mainly limited to the studies from the pre-optical coherence tomography era. By observing macular holes preoperatively we are able to determine the extent of the preoperative macular hole progression.
At our institution macular holes are treated in an elective setting. The majority of macular holes undergo a 2-step sequence of phacoemulsification and intraocular lens implantation followed by vitrectomy.
We wish to observe the effect of time and cataract surgery on the progression of macular holes prior to vitrectomy.
Looking for future studies?
Notify Me40 year–120 year
All sexes
Observational
Glostrup Municipality, 2600, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months preoperative
Serial optical coherence tomography (OCT) measurements in the preoperative period. The size of macular hole is determined by measuring the macular hole minimal linear diameter (µm).
Size and stage of macular hole is determined at primary evaluation at tertiary ophthalmic center. Initial scan is followed by pre-vitrectomy scan if patient is pseudophakic. Initial OCT scan is followed by pre- and postcataract as well as pre-vitrectomy OCT scan if patient is pseudophakic.
Time frame: 3 months postoperative
Visual acuity in ETDRS letters measured 3 month postoperatively
Glostrup University Hospital, Copenhagen
Other
Preoperative Progression of Macular Holes Using Optical Coherence Tomography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06915948
Eye Diseases, Macular Holes
Palakkad, Kerala, India
View Trial DetailsNCT05860985
Epiretinal Membrane, Eye Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT06560710
Eye Diseases, Macular Holes
View Trial DetailsNCT06323902
Eye Diseases, Macular Hole of Left Eye (Disorder)
Pasto, Departamento de Nariño, Colombia
View Trial Details